Dechert Advises HRA Pharma on Perrigo Company plc’s Acquisition Offer
Dechert advised HRA Pharma on Perrigo Company plc’s offer to acquire HRA Pharma, a leading global consumer self-care company, from funds affiliated with private equity firm Astorg and Goldman Sachs Asset Management.
The transaction is valued at €1.8 billion, or approximately US$2.1 billion in cash. HRA is one of the fastest growing over-the-counter ("OTC") companies globally, with three category-leading self-care brands in blister care (Compeed®), women's health (ellaOne®) and scar care (Mederma®).
The Dechert team was led by corporate partner Ross Allardice and associate Tony Brown and included national partner Delphin Boucher, associates Ruth Taylor, Daniel Mansfield, Gottfried Graf von Bassewitz and Sonja Feser and clerk Yan Boistay; litigation national partner Sophie Pelé and associates Jessica Garestier and Craig Watson; life sciences associate Margaux Lasseigne; and labor national partner Thibault Meiers and associate Viviane Valilou.
Dechert is a leading global law firm with 22 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.